Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 829 to 833 of 833 entries
Sorted by: Best Match Show Resources per page
Comparison of five polyethylene glycol precipitation procedures for the RT-qPCR based recovery of murine hepatitis virus, bacteriophage phi6, and pepper mild mottle virus as a surrogate for SARS-CoV-2 from wastewater.

The Science of the total environment

Torii S, Oishi W, Zhu Y, Thakali O, Malla B, Yu Z, Zhao B, Arakawa C, Kitajima M, Hata A, Ihara M, Kyuwa S, Sano D, Haramoto E, Katayama H.
PMID: 34610400
Sci Total Environ. 2021 Oct 03;807:150722. doi: 10.1016/j.scitotenv.2021.150722. Epub 2021 Oct 03.

Polyethylene glycol (PEG) precipitation is one of the conventional methods for virus concentration. This technique has been used to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in wastewater. The procedures and seeded surrogate viruses were different among...

Cite
Torii S, Oishi W, Zhu Y, et al. Comparison of five polyethylene glycol precipitation procedures for the RT-qPCR based recovery of murine hepatitis virus, bacteriophage phi6, and pepper mild mottle virus as a surrogate for SARS-CoV-2 from wastewater. Sci Total Environ. 2021;807:150722doi: 10.1016/j.scitotenv.2021.150722.
Torii, S., Oishi, W., Zhu, Y., Thakali, O., Malla, B., Yu, Z., Zhao, B., Arakawa, C., Kitajima, M., Hata, A., Ihara, M., Kyuwa, S., Sano, D., Haramoto, E., & Katayama, H. (2021). Comparison of five polyethylene glycol precipitation procedures for the RT-qPCR based recovery of murine hepatitis virus, bacteriophage phi6, and pepper mild mottle virus as a surrogate for SARS-CoV-2 from wastewater. The Science of the total environment, 807150722. https://doi.org/10.1016/j.scitotenv.2021.150722
Torii, Shotaro, et al. "Comparison of five polyethylene glycol precipitation procedures for the RT-qPCR based recovery of murine hepatitis virus, bacteriophage phi6, and pepper mild mottle virus as a surrogate for SARS-CoV-2 from wastewater." The Science of the total environment vol. 807 (2021): 150722. doi: https://doi.org/10.1016/j.scitotenv.2021.150722
Torii S, Oishi W, Zhu Y, Thakali O, Malla B, Yu Z, Zhao B, Arakawa C, Kitajima M, Hata A, Ihara M, Kyuwa S, Sano D, Haramoto E, Katayama H. Comparison of five polyethylene glycol precipitation procedures for the RT-qPCR based recovery of murine hepatitis virus, bacteriophage phi6, and pepper mild mottle virus as a surrogate for SARS-CoV-2 from wastewater. Sci Total Environ. 2021 Oct 03;807:150722. doi: 10.1016/j.scitotenv.2021.150722. Epub 2021 Oct 03. PMID: 34610400; PMCID: PMC8487407.
Copy Download .nbib Format: NLM
1,25-Dihydroxyvitamin D.

Redox biology

Nakajo T, Katayoshi T, Kitajima N, Tsuji-Naito K.
PMID: 34872043
Redox Biol. 2021 Dec 01;48:102203. doi: 10.1016/j.redox.2021.102203. Epub 2021 Dec 01.

The nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein (NLRP) inflammasome is a key inflammatory signaling pathway activated via a two-step signaling process consisting of priming and activation steps. Several studies have shown that 1,25-dihydroxyvitamin D3 (1,25(OH)

Cite
Nakajo T, Katayoshi T, Kitajima N, et al. 1,25-Dihydroxyvitamin D. Redox Biol. 2021;48:102203doi: 10.1016/j.redox.2021.102203.
Nakajo, T., Katayoshi, T., Kitajima, N., & Tsuji-Naito, K. (2021). 1,25-Dihydroxyvitamin D. Redox biology, 48102203. https://doi.org/10.1016/j.redox.2021.102203
Nakajo, Takahisa, et al. "1,25-Dihydroxyvitamin D." Redox biology vol. 48 (2021): 102203. doi: https://doi.org/10.1016/j.redox.2021.102203
Nakajo T, Katayoshi T, Kitajima N, Tsuji-Naito K. 1,25-Dihydroxyvitamin D. Redox Biol. 2021 Dec 01;48:102203. doi: 10.1016/j.redox.2021.102203. Epub 2021 Dec 01. PMID: 34872043.
Copy Download .nbib Format: NLM
A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations.

Internal medicine (Tokyo, Japan)

Yamamura Y, Furuichi K, Toyama T, Oshima M, Ogura H, Sato K, Nakagawa S, Miyagawa T, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Ikeda H, Toma T, Takasawa K, Yachie A, Wada T.
PMID: 34511567
Intern Med. 2021 Sep 11; doi: 10.2169/internalmedicine.7882-21. Epub 2021 Sep 11.

We herein report a 36-year-old man with repeated necrotizing lymphadenitis due to MEFV gene mutations. The patient's chief complaints were a fever and painful cervical lymphadenopathy. We diagnosed him with necrotizing lymphadenitis based on the pathological findings of the...

Cite
Yamamura Y, Furuichi K, Toyama T, et al. A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations. Intern Med. 2021;doi: 10.2169/internalmedicine.7882-21.
Yamamura, Y., Furuichi, K., Toyama, T., Oshima, M., Ogura, H., Sato, K., Nakagawa, S., Miyagawa, T., Kitajima, S., Hara, A., Iwata, Y., Sakai, N., Shimizu, M., Ikeda, H., Toma, T., Takasawa, K., Yachie, A., & Wada, T. (2021). A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations. Internal medicine (Tokyo, Japan), . https://doi.org/10.2169/internalmedicine.7882-21
Yamamura, Yuta, et al. "A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations." Internal medicine (Tokyo, Japan) vol. (2021). doi: https://doi.org/10.2169/internalmedicine.7882-21
Yamamura Y, Furuichi K, Toyama T, Oshima M, Ogura H, Sato K, Nakagawa S, Miyagawa T, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Ikeda H, Toma T, Takasawa K, Yachie A, Wada T. A Case of Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations. Intern Med. 2021 Sep 11; doi: 10.2169/internalmedicine.7882-21. Epub 2021 Sep 11. PMID: 34511567.
Copy Download .nbib Format: NLM
Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Hara H, Uemura Y, Hayakawa K, Togano T, Asai Y, Matsunaga N, Terada M, Ohtsu H, Kitajima K, Shimizu Y, Sato L, Ishikane M, Kinoshita-Iwamoto N, Shibata T, Kondo M, Izumi K, Sugiura W, Ohmagari N.
PMID: 34517044
Int J Infect Dis. 2021 Nov;112:111-116. doi: 10.1016/j.ijid.2021.09.014. Epub 2021 Sep 10.

OBJECTIVES: To determine whether anticoagulation therapy improves outcomes in patients with coronavirus disease 2019 (COVID-19) in Japan given their lower risk of thrombosis compared with Western cohorts.METHODS: The efficacy of anticoagulation therapy in hospitalized patients with COVID-19 was evaluated...

Cite
Hara H, Uemura Y, Hayakawa K, et al. Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan. Int J Infect Dis. 2021;112:111-116doi: 10.1016/j.ijid.2021.09.014.
Hara, H., Uemura, Y., Hayakawa, K., Togano, T., Asai, Y., Matsunaga, N., Terada, M., Ohtsu, H., Kitajima, K., Shimizu, Y., Sato, L., Ishikane, M., Kinoshita-Iwamoto, N., Shibata, T., Kondo, M., Izumi, K., Sugiura, W., & Ohmagari, N. (2021). Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 112111-116. https://doi.org/10.1016/j.ijid.2021.09.014
Hara, Hisao, et al. "Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 112 (2021): 111-116. doi: https://doi.org/10.1016/j.ijid.2021.09.014
Hara H, Uemura Y, Hayakawa K, Togano T, Asai Y, Matsunaga N, Terada M, Ohtsu H, Kitajima K, Shimizu Y, Sato L, Ishikane M, Kinoshita-Iwamoto N, Shibata T, Kondo M, Izumi K, Sugiura W, Ohmagari N. Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan. Int J Infect Dis. 2021 Nov;112:111-116. doi: 10.1016/j.ijid.2021.09.014. Epub 2021 Sep 10. PMID: 34517044; PMCID: PMC8432973.
Copy Download .nbib Format: NLM
Reply.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S.
PMID: 33786986
Liver Transpl. 2021 Aug;27(8):1217-1218. doi: 10.1002/lt.26058. Epub 2021 Jul 20.

No abstract available.

Cite
Kitajima T, Moonka D, Yeddula S, et al. Reply. Liver Transpl. 2021;27(8):1217-1218doi: 10.1002/lt.26058.
Kitajima, T., Moonka, D., Yeddula, S., Collins, K., Rizzari, M., Yoshida, A., Abouljoud, M. S., & Nagai, S. (2021). Reply. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 27(8), 1217-1218. https://doi.org/10.1002/lt.26058
Kitajima, Toshihiro, et al. "Reply." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society vol. 27,8 (2021): 1217-1218. doi: https://doi.org/10.1002/lt.26058
Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S. Reply. Liver Transpl. 2021 Aug;27(8):1217-1218. doi: 10.1002/lt.26058. Epub 2021 Jul 20. PMID: 33786986.
Copy Download .nbib Format: NLM
Showing 829 to 833 of 833 entries